DIAMIDEX is a biotechnology company that specializes in the quantification of microorganisms detection.
DIAMIDEX has raised $2.7M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2023.
DIAMIDEX's investors include Bpifrance, PureTerra Ventures, Incubateur Impulse, Total Developpement Regional, SATT Sud-Est.
DIAMIDEX is headquartered in Marseille, France.
DIAMIDEX is a biotechnology company that specializes in the quantification of microorganisms detection.
DIAMIDEX is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"DIAMIDEX — Funding & Investors." VCBacked, November 8, 2023, https://www.vcbacked.co/company/diamidex. Accessed August 14, 2026.
VCBacked. (2023). DIAMIDEX — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/diamidex
{{cite web |title=DIAMIDEX — Funding & Investors |url=https://www.vcbacked.co/company/diamidex |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated